VenuSilk
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
VenuSilk - overview
Established
2025
Location
Suzhou, Jiangsu, China
Primary Industry
Healthcare
About
Founded in 2025 and based in Suzhou, China, VenuSilk is a high-tech enterprise focused on the research and development of medical aesthetic products. The company's founder, Dr. Gong Zuguang graduated from Fudan University with a degree in polymer chemistry and physics. In March 2025, VenuSilk closed angel funding from new investor Hanchi Venture.
In October 2025, VenuSilk closed pre-series A funding led by new investor Huaige Capital, with participation from returning investor Hanchi Venture. VenuSilk develops injectable silk fibroin gel products that provides support for human skin and promote the long-term regeneration of collagen. The company generates revenue from providing medical aesthetic products. Pre-Series A of financing will support the company's technological advancement and product development in the field of medical aesthetics materials, further enhancing its R&D efficiency and market competitiveness.
Current Investors
Huaige Capital, ChuangVest Ventures
Primary Industry
Healthcare
Sub Industries
Beauty & Hygiene, Healthcare, Healthcare Specialists
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.